Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 August 2006, Vol. 108, No. 3, pp. 1045-1049.
Prepublished online as a Blood First Edition Paper on March 30, 2006; DOI 10.1182/blood-2006-01-0261.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-01-0261v1
108/3/1045    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tissing, W. J
Right arrow Articles by Pieters, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tissing, W. J
Right arrow Articles by Pieters, R.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted January 20, 2006
Accepted March 16, 2006

Glucocorticoid-induced glucocorticoid receptor expression and promoter-usage is not linked to glucocorticoid resistance in childhood ALL

Wim J Tissing, Jules P Meijerink*, Bas Brinkhof, Mathilde J Broekhuis, Renee X Menezes, Monique L den Boer, and Rob Pieters

Dept of Pediatric Oncology / Hematology, ErasmusMC - Sophia Childrens Hospital, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands; Dept of Pediatric Oncology / Hematology, University of Groningen and University Medical Center Groningen, Beatrix Childrens Hospital, Groningen, The Netherlands
Dept of Pediatric Oncology / Hematology, ErasmusMC - Sophia Childrens Hospital, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
Dept of Pediatric Oncology / Hematology, ErasmusMC - Sophia Childrens Hospital, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands; Dept of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands

* Corresponding author; email: j.p.p.meijerink{at}erasmusmc.nl.

Glucocorticoid (GC) resistance is an adverse prognostic factor in childhood ALL, but little is known about causes of GC resistance. Upregulation of the glucocorticoid receptor (GR) has been suggested as an essential step to the induction of apoptosis in leukemic cells. In this study we investigated whether base-line mRNA expression levels of the five different GR promoters transcripts (1A1, 1A2, 1A3, 1B and 1C) or differences in the degree of regulation of the GR or GR promoter transcripts upon GC exposure are related to GC resistance. Therefore, mRNA levels of the five GR promoter transcripts and of the GR were measured by quantitative real-time RT-PCR (Taqman) technology in primary ALL cells prior to and after 3, 8 and 24 hours of prednisolone exposure. GR expression is induced upon GC exposure in primary ALL patient samples, which is opposite to what is found in tissues in which GCs do not induce apoptosis. GC resistance in childhood ALL can not be attributed to an inability of resistant cells to upregulate the expression of the GR upon GC exposure, nor to differences in GR promoter usage (at base-line and upon GC exposure).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Glucocorticoid resistance: a persistent riddle
Bruce M. Camitta
Blood 2006 108: 787-788. [Full Text] [PDF]



This article has been cited by other articles:


Home page
BloodHome page
B. C. Bornhauser, L. Bonapace, D. Lindholm, R. Martinez, G. Cario, M. Schrappe, F. K. Niggli, B. W. Schafer, and J.-P. Bourquin
Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway
Blood, September 15, 2007; 110(6): 2084 - 2091.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. S. Bachmann, R. Gorman, R. A. Papa, J. E. Bardell, J. Ford, U. R. Kees, G. M. Marshall, and R. B. Lock
Divergent Mechanisms of Glucocorticoid Resistance in Experimental Models of Pediatric Acute Lymphoblastic Leukemia
Cancer Res., May 1, 2007; 67(9): 4482 - 4490.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
E. Presul, S. Schmidt, R. Kofler, and A. Helmberg
Identification, tissue expression, and glucocorticoid responsiveness of alternative first exons of the human glucocorticoid receptor
J. Mol. Endocrinol., January 1, 2007; 38(1): 79 - 90.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020